Leave Your Message
products-news-banners02

Peptide API

Accumulation of peptide active pharmaceutical ingredient technology, expansion of oligonucleotides and complex active pharmaceutical ingredients

    Semaglutide (Chemical synthesis)Semaglutide (Chemical synthesis)
    01

    Semaglutide (Chemical synthesis)

    Polypeptide
    CAS:910463-68-2
    Status:DMF, WC
    Indications:Endocrine, nutritional, and metabolic diseases
    Semaglutide (Semi-Recombinant)Semaglutide (Semi-Recombinant)
    02

    Semaglutide (Semi-Recombinant)

    Polypeptide
    CAS:910463-68-2
    Status:DMF, WC
    Indications:Endocrine, nutritional, and metabolic diseases
    LiraglutideLiraglutide
    03

    Liraglutide

    Polypeptide
    CAS:204656-20-2
    Status:DMF, TGA, NMPA, WC
    Indications:Endocrine, nutritional, and metabolic diseases
    LinaclotideLinaclotide
    04

    Linaclotide

    Polypeptide
    CAS:851199-59-2
    Status:DMF, NMPA, WC
    Indications:Diseases of the digestive system
    PlecanatidePlecanatide
    05

    Plecanatide

    Polypeptide
    CAS:467426-54-6
    Status:Validation Completed, DMF (2025)
    Indications:Diseases of the digestive system
    DegarelixDegarelix
    06

    Degarelix

    Polypeptide
    CAS:214766-78-6
    Status:DMF, NMPA
    Indications:Neoplasms
    GlatiramerGlatiramer
    07

    Glatiramer

    Polypeptide
    CAS:147245-92-9
    Status:DMF
    Indications:Nervous System Diseases
    OxytocinOxytocin
    08

    Oxytocin

    Polypeptide
    CAS:50-56-6
    Status:DMF, CEP, NMPA, WC
    Indications:Pregnancy, childbirth, and puerperium
    FirstPrev12345NextLastTotal 10

    Product Pipeline

    API  Indications Status
    Semaglutide (Chemical synthesis) Endocrine, Nutritional and Metabolic Diseases DMF, WC
    Semaglutide (Semi-Recombinant) Endocrine, Nutritional and Metabolic Diseases DMF, WC
    Liraglutide Endocrine, Nutritional and Metabolic Diseases DMF, TGA, NMPA, WC
    Linaclotide Digestive System Diseases DMF, NMPA, WC
    Degarelix Neoplasms DMF, NMPA
    Glatiramer Nervous System Diseases DMF
    Oxytocin Pregnancy, Childbirth and Puerperium DMF, CEP, NMPA, WC
    Desmopressin Endocrine, Nutritional and Metabolic Diseases DMF, CEP, KDMF, NMPA, WC
    Cetrorelix Pregnancy, Childbirth and Puerperium DMF, NMPA
    Somatostatin Digestive System Diseases CEP, NMPA, WC
    Carbetocin Pregnancy, Childbirth and Puerperium ASMF, NMPA, WC
    Teriparatide Musculoskeletal System and Connective Tissue Diseases DMF, NMPA
    Tirzepatide Endocrine, Nutritional and Metabolic Diseases DMF, NMPA
    Thymalfasin Certain Infectious and Parasitic Diseases NMPA
    Ganirelix Pregnancy, Childbirth and Puerperium DMF, ASMF, TGA, NMPA, WC
    Eptifibatide Diseases of the Circulatory System DMF, NMPA, WC
    Abaloparatide Musculoskeletal System and Connective Tissue Diseases DMF
    Atosiban Pregnancy, Childbirth and Puerperium ASMF, NMPA, WC
    Bivalirudin Diseases of the Circulatory System and Diseases of the Blood and Hematopoietic Organs DMF
    Calcitonin (salmon) Musculoskeletal System and Connective Tissue Diseases NMPA
    Exenatide Endocrine, Nutritional and Metabolic Diseases NMPA
    Glucagon Endocrine, Nutritional and Metabolic Diseases NMPA
    Leuprorelin Neoplasms and Diseases of the Genitourinary System CEP
    Nesiritide Diseases of the Circulatory System DMF
    Octreotide Neoplasms and Endocrine, Nutritional and Metabolic Diseases CEP, NMPA, WC
    Protirelin Factors Influencing Health Status NMPA
    Terlipressin Digestive System Diseases and Diseases of the Genitourinary System CEP,NMPA, WC
    Thymopentin Certain Infectious and Parasitic Diseases and Factors Influencing Health Status NMPA
    Triptorelin Neoplasms and Diseases of the Genitourinary System NMPA
    Cannabidiol Nervous System Diseases DMF
    Plecanatide Digestive System Diseases Validation Completed, DMF (2025)
    Difelikefalin Diseases of the Genitourinary System Validation Completed, DMF (2025)
    Inclisiran Endocrine, Nutritional and Metabolic Diseases R&D
    Retatrutide Endocrine, Nutritional and Metabolic Diseases R&D
    Etelcalcetide Diseases of the Genitourinary System DMF (2025)
    Lanreotide Neoplasms and Endocrine, Nutritional and Metabolic Diseases DMF (2025)
    Apraglutide Digestive System Diseases R&D
    Pegcetacoplan Diseases of the Blood and Hematopoietic Organs R&D
    Bulevirtide Mental and Behavioral Disorders R&D
    Cagrilintide Endocrine, Nutritional and Metabolic Diseases R&D
    Elamipretide Neoplasms R&D
    Motixafortide Endocrine, Nutritional and Metabolic Diseases R&D
    Palopegteriparatide Endocrine, Nutritional and Metabolic Diseases R&D
    Rusfertide Diseases of the Blood and Hematopoietic Organs R&D
    Sermelanotide Endocrine, Nutritional and Metabolic Diseases R&D
    Survodutide Diseases of the Circulatory System R&D
    Glepaglutide Digestive System Diseases R&D
    Trofinetide Nervous System Diseases R&D
    Vasopressin Endocrine, Nutritional and Metabolic Diseases and Symptoms, Signs R&D
    Ziconotide Nervous System Diseases R&D
    Donidalorsen Diseases of the Blood and Hematopoietic Organs R&D
    Fitusiran Diseases of the Blood and Hematopoietic Organs R&D
    Givosiran Endocrine, Nutritional and Metabolic Diseases R&D
    Plozasiran Endocrine, Nutritional and Metabolic Diseases R&D
    Zilebesiran Diseases of the Circulatory System R&D
    Orforglipron Endocrine, Nutritional and Metabolic Diseases R&D
    Enlicitide Decanoate Endocrine, Nutritional and Metabolic Diseases R&D
    Ferric carboxymaltose Diseases of the Blood and Hematopoietic Organs R&D
    Remark：Singapore（SGP ）; Saudi Arabia（KSA ）; Jordan（JOR ）; Russia（RUS）; Columbia（COL ）; New Zealand（NZL）; Mexico（MEX）; Macedonia（MKD）; Bangladesh（BGD）; Israel（ISR）；Vietnam（VNM）；Canada（CAN）